We are live on
!
Find out more
ECP
Empyrean Capital Partners Portfolio holdings
AUM
$3.03B
1-Year Est. Return
47.81%
This Fund
S&P 500
This Quarter
Est. Return
+1.18%
1 Year Est. Return
+47.81%
3 Year Est. Return
+131.37%
5 Year Est. Return
+161.39%
10 Year Est. Return
+590.42%
AUM
$2.01B
AUM Growth
+$256M
(+15%)
Cap. Flow
-$43.5M
Cap. Flow
% of AUM
-2.17%
Top 10 Holdings %
Top 10 Hldgs %
52.49%
Holding
70
New
18
Increased
9
Reduced
5
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$139M |
| 2 |
Applied Materials
AMAT
|
+$108M |
| 3 |
Aramark
ARMK
|
+$57.8M |
| 4 |
AbbVie
ABBV
|
+$57.4M |
| 5 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$97.3M |
| 2 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$79.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$58.5M |
| 4 |
AGN
Allergan plc
AGN
|
+$56.5M |
| 5 |
Dollar General
DG
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 32.72% |
| 2 | Technology | 20.3% |
| 3 | Financials | 12.21% |
| 4 | Healthcare | 9.53% |
| 5 | Energy | 7.6% |
Similar funds
SI
EGA
HFM
BCM
CPC
CA
NCM
GFA
Empyrean Capital Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Empyrean Capital Partners held 70 positions worth $2.01B, up 15% from $1.76B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Empyrean Capital Partners's Q1 2015 filing shows 18 new, 9 increased, 5 reduced and 15 closed positions. Its largest new stake was DIRECTV COM STK (DE): 1,606,622 shares worth $137M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.
- Empyrean Capital Partners's largest Q1 2015 buy was DIRECTV COM STK (DE): 1,606,622 shares worth $137M.
- Empyrean Capital Partners added most to Applied Materials in Q1 2015, an estimated $108M increase.
- Empyrean Capital Partners's biggest Q1 2015 reduction was Allergan plc, cutting an estimated $56.5M.
- Empyrean Capital Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $97.3M.
- Empyrean Capital Partners's ten largest holdings make up 52% of its $2.01B portfolio in Q1 2015.
- Empyrean Capital Partners opened 18 new positions and closed 15 in Q1 2015.
- Empyrean Capital Partners's portfolio value rose 15% quarter-over-quarter to $2.01B.
Based on Empyrean Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.